Sir, I refer to your editorial1 Read all about it and to the difficulty of bringing new work to the attention of both the profession and those who could formalise and further the research.

It seems almost impossible to bring serendipitous discoveries into the mainstream of the professional publications. There are by definition no references to other articles or other researchers' work. It would be a useful extra in your journal to have a section for appeals for collaboration in or extension of new work.

In this context I put a personal appeal for assistance with a trial of orally ingested palmitoyl ascorbate as a total suppressor of the pain of trigeminal neuralgia (TN). This has now been used by enough people to give great hope that it would be universally useful in this distressing condition. It has already been instrumental in being able to avoid surgery for a patient listed for it. Assistance and funding for a formal trial from those better qualified than me would be welcome.